Progress in the application of molecular imaging in psychiatric disorders

Jia Tan; Guangying Zhang; Jiaqi Hao; Huawei Cai; Dingping Wu; Zhuoxiao Su; Beibei Liu; Min Wu

doi:10.1093/psyrad/kkad020

Progress in the application of molecular imaging in psychiatric disorders

Psychoradiology. 2023 Oct 9:3:kkad020. doi: 10.1093/psyrad/kkad020. eCollection 2023.

Authors

Jia Tan^{1

2}, Guangying Zhang³, Jiaqi Hao^{1

2}, Huawei Cai⁴, Dingping Wu¹, Zhuoxiao Su¹, Beibei Liu¹, Min Wu^{1

2}

Affiliations

¹ Department of Radiology and Huaxi MR Research Center (HMRRC), Functional and Molecular Imaging Key Laboratory of Sichuan Province, West China Hospital, Sichuan University, Chengdu 610041, China.
² Research Unit of Psychoradiology, Chinese Academy of Medical Sciences, Chengdu 610041, China.
³ Department of Radiology, Banan People's Hospital, Chongqing Medical University, Chongqing 400037, China.
⁴ Department of Nuclear Medicine and Laboratory of Clinical Nuclear Medicine, West China Hospital, Sichuan University, Chengdu 610041, China.

Abstract

Psychiatric disorders have always attracted a lot of attention from researchers due to the difficulties in their diagnoses and treatments. Molecular imaging, as an emerging technology, has played an important role in the researchers of various diseases. In recent years, molecular imaging techniques including magnetic resonance spectroscopy, nuclear medicine imaging, and fluorescence imaging have been widely used in the study of psychiatric disorders. This review will briefly summarize the progression of molecular imaging in psychiatric disorders.

Keywords: fluorescent molecular probe; magnetic resonance spectroscopy; molecular imaging; positron emission computed tomography; psychiatric disorders; single photon emission computed tomography.